Practice patterns for post-prostatectomy hormonal therapy amongst Canadian radiation oncologists

Canadian Journal of Urology

Volumn 17, Issue 6, 2010, Pages 5436-5441

  Baxi, Siddhartha ^a   Catton, Charles ^a  

^a PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

Androgen deprivation therapy; Postoperative radiotherapy; Prostate cancer

Indexed keywords

ANTIANDROGEN; PROSTATE SPECIFIC ANTIGEN;

ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; ARTICLE; BLOOD; CANADA; CLINICAL PRACTICE; HUMAN; INFORMATION PROCESSING; MALE; ONCOLOGY; PATHOLOGY; PROSTATE TUMOR; PROSTATECTOMY; STATISTICS;

ANDROGEN ANTAGONISTS; CANADA; CHEMOTHERAPY, ADJUVANT; DATA COLLECTION; HUMANS; MALE; PHYSICIAN'S PRACTICE PATTERNS; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; RADIATION ONCOLOGY; RADIOTHERAPY, ADJUVANT;

EID: 79953768385     PISSN: 11959479     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Bolla M, van Poppel H, Collette L et al. Postoperative radiotherapy after radical prostatectomy: a randomised controlled trial (EORTC trial 22911). Lancet 2005;366(9485):572-578.
2. Thompson IM Jr, Tangen CM, Paradelo J et al. Adjuvant radiotherapy for pathologically advanced prostate cancer: a randomized clinical trial. JAMA 2006;296(19):2329-2335.
3. Wiegel T, Bottke D, Steiner U et al. Phase III postoperative adjuvant radiotherapy after radical prostatectomy compared with radical prostatectomy alone in pT3 prostate cancer with postoperative undetectable prostate-specific antigen: ARO 96-02/AUO AP 09/95. J Clin Oncol 2009;27(18):2924-2930.
4. Chalasani V, Iansavichene AE, Lock M, Izawa JI. Salvage radiotherapy following radical prostatectomy. Int J Urol 2009;16(1):31-36.
5. Stephenson AJ, Scardino PT, Kattan MW et al. Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy. J Clin Oncol 2007;25(15):2035-2041.
6. Sia M, Pickles T, Morton G, Souhami L, Lukka H, Warde P. Salvage radiotherapy following biochemical relapse after radical prostatectomy: proceedings of the Genito-Urinary Radiation Oncologists of Canada consensus meeting. Can Urol Assoc J 2008;2(5):500-507.
7. Bolla M, de Reijke TM, Van Tienhoven G et al. Duration of androgen suppression in the treatment of prostate cancer. N Engl J Med 2009;360(24):2516-2527.
8. Katz MS, Zelefsky MJ, Venkatraman ES, Fuks Z, Hummer A, Leibel SA. Predictors of biochemical outcome with salvage conformal radiotherapy after radical prostatectomy for prostate cancer. J Clin Oncol 2003;21(3):483-489.
9. Song DY, Thompson TL, Ramakrishnan V et al. Salvage radiotherapy for rising or persistent PSA after radical prostatectomy. Urology 2002;60(2):281-287.
10. Taylor N, Kelly JF, Kuban DA, Babaian RJ, Pisters LL, Pollack A. Adjuvant and salvage radiotherapy after radical prostatectomy for prostate cancer. Int J Radiat Oncol Biol Phys 2003;56(3):755-763.
11. Israeli RS, Ryan CW, Jung LL. Managing bone loss in men with locally advanced prostate cancer receiving androgen deprivation therapy. J Urol 2008;179(2):414-423.
12. Keating NL, O'Malley AJ, Smith MR. Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer. J Clin Oncol 2006;24(27):4448-4456.
13. [Internet] EORTC. Post-operative external radiotherapy combined with concomitant and adjuvant hormonal treatment versus post-operative external radiotherapy alone in pathological stage pT3a-b R0-1/pT2R1 N0M0, Gleason score 5-10 prostatic carcinoma. A phase III study.; 2009 [updated 2009; cited]; Available from: http://www.eortc.be/protoc/Details.asp?Protocol=30041.
14. [Internet] NCIC. RADICALS: Radiotherapy and Androgen Deprivation In Combination After Local Surgery.; 2009 [updated 2009; cited 2010]; Available from: http://www.ctg.queensu.ca/public/Clinical_Trials/public_ph_3_trial_summary.html#PR13.
15. Yokomizo A, Kawamoto H, Nihei K et al. Randomized controlled trial to evaluate radiotherapy +/- endocrine therapy versus endocrine therapy alone for PSA failure after radical prostatectomy: Japan Clinical Oncology Group Study JCOG 0401. Jpn J Clin Oncol 2005;35(1):34-36.
16. Lee LW, Clarke NW, Ramani VAC, Cowan RA, Wylie JP, Logue JP. Adjuvant and salvage treatment after radical prostatectomy: current practice in the UK. Prostate Cancer Prostatic Dis 2005;8(3):229-234.
17. Morris SL, Parker C, Huddart R, Horwich A, Dearnaley D. Current opinion on adjuvant and salvage treatment after radical prostatectomy. Clin Oncol (R Coll Radiol) 2004;16(4):277-282.
18. Vergis R, Corbishley CM, Norman AR et al. Intrinsic markers of tumour hypoxia and angiogenesis in localised prostate cancer and outcome of radical treatment: a retrospective analysis of two randomised radiotherapy trials and one surgical cohort study. Lancet Oncol 2008;9(4):342-351.
19. Zietman AL, Prince EA, Nakfoor BM, Park JJ. Androgen deprivation and radiation therapy: sequencing studies using the Shionogi in vivo tumor system. Int J Radiat Oncol Biol Phys 1997;38(5):1067-1070.
20. Kasibhatla M, Peterson B, Anscher MS. What is the best postoperative treatment for patients with pT3bN0M0 adenocarcinoma of the prostate? Prostate Cancer Prostatic Dis 2005;8(2):167-173.
21. King CR, Presti JC, Jr., Gill H, Brooks J, Hancock SL. Radiotherapy after radical prostatectomy: does transient androgen suppression improve outcomes? Int J Radiat Oncol Biol Phys 2004;59(2):341-347.
22. [Internet] RTOG. A PHASE III trial of radiation therapy with or without casodex in patients with PSA elevation following radical prostatectomy for PT3N0 carcinoma of the prosatate.;2006 [updated 2006; cited]; Available from: http://www.rtog.org/members/protocols/96-01/96-01.pdf.
23. Tyrrell CJ, Payne H, See WA et al. Bicalutamide ('Casodex') 150 mg as adjuvant to radiotherapy in patients with localised or locally advanced prostate cancer: results from the randomised Early Prostate Cancer Programme. Radiother Oncol 2005;76(1):4-10.
24. Walz J, Chun FK, Klein EA et al. Nomogram predicting the probability of early recurrence after radical prostatectomy for prostate cancer. J Urol 2009;181(2):601-607;discussion 7-8.